• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种小规模体外实验装置在早期制剂研发中评估亲脂性弱碱的腔内沉淀方面的实用性

On the Usefulness of Two Small-Scale In Vitro Setups in the Evaluation of Luminal Precipitation of Lipophilic Weak Bases in Early Formulation Development.

作者信息

O'Dwyer Patrick J, Imanidis Georgios, Box Karl J, Reppas Christos

机构信息

Pion Inc. (UK) Ltd., Forest Row, East Sussex RH18 5DW, UK.

Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, GR 157 84 Zografou, Greece.

出版信息

Pharmaceutics. 2020 Mar 16;12(3):272. doi: 10.3390/pharmaceutics12030272.

DOI:10.3390/pharmaceutics12030272
PMID:32188116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7151110/
Abstract

A small-scale biphasic dissolution setup and a small-scale dissolution-permeation (D-P) setup were evaluated for their usefulness in simulating the luminal precipitation of three lipophilic weak bases-dipyridamole, ketoconazole and itraconazole. The transition from the gastric to intestinal environment was incorporated into both experimental procedures. Emulsification during the biphasic dissolution experiments had a minimal impact on the data, when appropriate risk mitigation steps were incorporated. Precipitation parameters estimated from the in vitro data were inputted into the Simcyp® physiologically based pharmacokinetic (PBPK) modelling software and simulated human plasma profiles were compared with previously published pharmacokinetic data. Average C and AUC values estimated using experimentally derived precipitation parameters from the biphasic experiments deviated from corresponding published actual values less than values estimated using the default simulator parameters for precipitation. The slow rate of transport through the biomimetic membrane in the D-P setup limited its usefulness in forecasting the rates of in vivo precipitation used in the modelling of average plasma profiles.

摘要

评估了小规模双相溶出装置和小规模溶出-渗透(D-P)装置在模拟三种亲脂性弱碱(双嘧达莫、酮康唑和伊曲康唑)的腔内沉淀方面的实用性。两种实验方法都纳入了从胃环境到肠道环境的转变。在双相溶出实验中,当纳入适当的风险缓解措施时,乳化对数据的影响最小。将从体外数据估计的沉淀参数输入到Simcyp®基于生理的药代动力学(PBPK)建模软件中,并将模拟的人体血浆曲线与先前发表的药代动力学数据进行比较。使用双相实验中实验得出的沉淀参数估计的平均C和AUC值与相应公布的实际值的偏差小于使用沉淀默认模拟器参数估计的值。D-P装置中通过仿生膜的传输速率较慢,限制了其在预测用于平均血浆曲线建模的体内沉淀速率方面的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/ae028c516e05/pharmaceutics-12-00272-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/f3c5a3927750/pharmaceutics-12-00272-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/f3b2761c2716/pharmaceutics-12-00272-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/d7b6085ba800/pharmaceutics-12-00272-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/286babc05327/pharmaceutics-12-00272-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/0552c8aacd12/pharmaceutics-12-00272-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/523f258dc23b/pharmaceutics-12-00272-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/fd86af542e65/pharmaceutics-12-00272-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/293f36a065c1/pharmaceutics-12-00272-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/4a5a7c5042b2/pharmaceutics-12-00272-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/2d90c43dc73c/pharmaceutics-12-00272-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/c5b77bb5cfc5/pharmaceutics-12-00272-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/6eee0485630f/pharmaceutics-12-00272-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/ae028c516e05/pharmaceutics-12-00272-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/f3c5a3927750/pharmaceutics-12-00272-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/f3b2761c2716/pharmaceutics-12-00272-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/d7b6085ba800/pharmaceutics-12-00272-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/286babc05327/pharmaceutics-12-00272-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/0552c8aacd12/pharmaceutics-12-00272-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/523f258dc23b/pharmaceutics-12-00272-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/fd86af542e65/pharmaceutics-12-00272-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/293f36a065c1/pharmaceutics-12-00272-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/4a5a7c5042b2/pharmaceutics-12-00272-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/2d90c43dc73c/pharmaceutics-12-00272-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/c5b77bb5cfc5/pharmaceutics-12-00272-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/6eee0485630f/pharmaceutics-12-00272-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07b/7151110/ae028c516e05/pharmaceutics-12-00272-g013.jpg

相似文献

1
On the Usefulness of Two Small-Scale In Vitro Setups in the Evaluation of Luminal Precipitation of Lipophilic Weak Bases in Early Formulation Development.两种小规模体外实验装置在早期制剂研发中评估亲脂性弱碱的腔内沉淀方面的实用性
Pharmaceutics. 2020 Mar 16;12(3):272. doi: 10.3390/pharmaceutics12030272.
2
On the usefulness of four in vitro methods in assessing the intraluminal performance of poorly soluble, ionisable compounds in the fasted state.在评估空腹状态下难溶性、离解性化合物腔内性能方面,四种体外方法的有用性。
Eur J Pharm Sci. 2022 Jan 1;168:106034. doi: 10.1016/j.ejps.2021.106034. Epub 2021 Oct 7.
3
An in vitro methodology for forecasting luminal concentrations and precipitation of highly permeable lipophilic weak bases in the fasted upper small intestine.一种用于预测空腹上小肠中高渗透性亲脂性弱碱的腔内浓度和沉淀的体外方法。
Pharm Res. 2012 Dec;29(12):3486-98. doi: 10.1007/s11095-012-0844-z. Epub 2012 Aug 14.
4
Prediction of Ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modelling.使用更新的体外转运模型结合生理药代动力学建模预测酮康唑的吸收情况。
Eur J Pharm Sci. 2017 Mar 30;100:42-55. doi: 10.1016/j.ejps.2016.12.017. Epub 2016 Dec 21.
5
Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.在禁食状态下,小肠中的沉淀可能在难溶性弱碱性药物的体内性能中发挥更重要的作用:以奈非那韦为例。
Eur J Pharm Biopharm. 2011 Oct;79(2):349-56. doi: 10.1016/j.ejpb.2011.04.005. Epub 2011 Apr 18.
6
Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.桂利嗪口服吸收的预测——一种具有临界渗透性的高度过饱和难溶性弱碱。
Eur J Pharm Biopharm. 2014 Nov;88(3):795-806. doi: 10.1016/j.ejpb.2014.08.011. Epub 2014 Sep 6.
7
The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS).使用体内预测性溶出系统——胃肠道模拟器(GIS)研究过饱和水平对BCS IIb类药物双嘧达莫和酮康唑口服吸收的影响。
Eur J Pharm Sci. 2017 May 1;102:126-139. doi: 10.1016/j.ejps.2017.02.042. Epub 2017 Mar 3.
8
Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.基于模型的生物药剂学实验分析,以改善机制口服吸收建模:以酮康唑为模型药物的体外-体内外推综合视角。
Mol Pharm. 2017 Dec 4;14(12):4305-4320. doi: 10.1021/acs.molpharmaceut.7b00406. Epub 2017 Aug 25.
9
In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole.计算机模拟方法评价泊沙康唑的胃肠道溶出度、过饱和度和沉淀。
Mol Pharm. 2017 Dec 4;14(12):4321-4333. doi: 10.1021/acs.molpharmaceut.7b00396. Epub 2017 Sep 5.
10
Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs.从体外多室传递系统中整合沉淀动力学和机制性口服吸收模型以预测弱碱性药物的药代动力学。
J Pharm Sci. 2019 Jan;108(1):574-583. doi: 10.1016/j.xphs.2018.10.051. Epub 2018 Nov 3.

引用本文的文献

1
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report.生理药代动力学模型参数化:研讨会总结报告。
Mol Pharm. 2024 Aug 5;21(8):3697-3731. doi: 10.1021/acs.molpharmaceut.4c00526. Epub 2024 Jun 30.
2
Supersaturation Behavior: Investigation of Polymers Impact on Nucleation Kinetic Profile for Rationalizing the Polymeric Precipitation Inhibitors.过饱和度行为:研究聚合物对成核动力学曲线的影响,以合理设计聚合物沉淀抑制剂。
Curr Drug Deliv. 2024;21(10):1422-1432. doi: 10.2174/0115672018261505231018100329.
3
Development and Application of a Dissolution-Transfer-Partitioning System (DTPS) for Biopharmaceutical Drug Characterization.

本文引用的文献

1
Biphasic drug release testing coupled with diffusing wave spectroscopy for mechanistic understanding of solid dispersion performance.双相药物释放测试结合漫射波光谱法,用于深入了解固体分散体的性能。
Eur J Pharm Sci. 2019 Sep 1;137:105001. doi: 10.1016/j.ejps.2019.105001. Epub 2019 Jul 10.
2
Surface Dissolution UV Imaging for Investigation of Dissolution of Poorly Soluble Drugs and Their Amorphous Formulation.表面溶解紫外成像技术用于研究难溶性药物及其无定形制剂的溶解情况。
AAPS PharmSciTech. 2019 Feb 13;20(3):113. doi: 10.1208/s12249-019-1317-z.
3
Biopharmaceutic IVIVE-Mechanistic Modeling of Single- and Two-Phase In Vitro Experiments to Obtain Drug-Specific Parameters for Incorporation Into PBPK Models.
用于生物制药药物表征的溶出-转移-分配系统(DTPS)的开发与应用
Pharmaceutics. 2023 Mar 26;15(4):1069. doi: 10.3390/pharmaceutics15041069.
4
Integrating In Vitro Biopharmaceutics into Physiologically Based Biopharmaceutic Model (PBBM) to Predict Food Effect of BCS IV Zwitterionic Drug (GSK3640254).将体外生物药剂学整合到基于生理的生物药剂学模型(PBBM)中,以预测BCS IV类两性离子药物(GSK3640254)的食物效应。
Pharmaceutics. 2023 Feb 3;15(2):521. doi: 10.3390/pharmaceutics15020521.
5
Non-Effective Improvement of Absorption for Some Nanoparticle Formulations Explained by Permeability under Non-Sink Conditions.非漏槽条件下渗透性对某些纳米颗粒制剂吸收的无效改善作用
Pharmaceutics. 2022 Apr 7;14(4):816. doi: 10.3390/pharmaceutics14040816.
6
On the usefulness of four in vitro methods in assessing the intraluminal performance of poorly soluble, ionisable compounds in the fasted state.在评估空腹状态下难溶性、离解性化合物腔内性能方面,四种体外方法的有用性。
Eur J Pharm Sci. 2022 Jan 1;168:106034. doi: 10.1016/j.ejps.2021.106034. Epub 2021 Oct 7.
7
Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions.羟丙甲纤维素醋酸琥珀酸酯对聚乙烯醇塞来昔布无定形固体分散体溶出性能的影响
Pharmaceutics. 2020 Jun 11;12(6):541. doi: 10.3390/pharmaceutics12060541.
生物制药 IVIVE-单相和两相体外实验的机制建模,以获得药物特异性参数并将其纳入 PBPK 模型。
J Pharm Sci. 2019 Apr;108(4):1604-1618. doi: 10.1016/j.xphs.2018.11.034. Epub 2018 Nov 23.
4
In-line derivative spectroscopy as a promising application to a small-scale in vitro transfer model in biorelevant supersaturation and precipitation testing.在线导数光谱法作为一种有前途的应用,可用于生物相关过饱和度和沉淀试验中的小规模体外传递模型。
J Pharm Pharmacol. 2018 Oct;70(10):1315-1323. doi: 10.1111/jphp.12991. Epub 2018 Jul 30.
5
Linking the concentrations of itraconazole and 2-hydroxypropyl-β-cyclodextrin in human intestinal fluids after oral intake of Sporanox.口服斯皮仁诺后,人肠液中伊曲康唑与 2-羟丙基-β-环糊精浓度的关联。
Eur J Pharm Biopharm. 2018 Nov;132:231-236. doi: 10.1016/j.ejpb.2018.06.025. Epub 2018 Jun 27.
6
In vitro methods to assess drug precipitation in the fasted small intestine - a PEARRL review.评估空腹状态下小肠中药物沉淀的体外方法 - PEARRL 综述。
J Pharm Pharmacol. 2019 Apr;71(4):536-556. doi: 10.1111/jphp.12951. Epub 2018 Jun 28.
7
Ranking Itraconazole Formulations Based on the Flux through Artificial Lipophilic Membrane.基于人工亲脂膜透过率对伊曲康唑制剂进行排名。
Pharm Res. 2018 Jun 20;35(8):161. doi: 10.1007/s11095-018-2440-3.
8
A Modified In Situ Method to Determine Release from a Complex Drug Carrier in Particle-Rich Suspensions.一种改进的原位方法,用于测定富含颗粒的悬浮液中复杂药物载体的释放。
AAPS PharmSciTech. 2018 Oct;19(7):2859-2865. doi: 10.1208/s12249-018-1024-1. Epub 2018 Jun 6.
9
Physiologically Based Absorption Modeling of Salts of Weak Bases Based on Data in Hypochlorhydric and Achlorhydric Biorelevant Media.基于低胃酸和无胃酸生物相关介质中数据的弱碱盐的生理相关吸收模型。
AAPS PharmSciTech. 2018 Oct;19(7):2851-2858. doi: 10.1208/s12249-018-1059-3. Epub 2018 Jun 5.
10
The BioGIT System: a Valuable In Vitro Tool to Assess the Impact of Dose and Formulation on Early Exposure to Low Solubility Drugs After Oral Administration.BioGIT 系统:一种评估口服给予低溶解度药物后早期暴露于剂量和剂型影响的有价值的体外工具。
AAPS J. 2018 May 24;20(4):71. doi: 10.1208/s12248-018-0231-8.